Comment on shortened treatment with nimodipine in aneurysmal subarachnoid hemorrhage
- PMID: 40895034
- PMCID: PMC12398914
- DOI: 10.1016/j.bas.2025.104394
Comment on shortened treatment with nimodipine in aneurysmal subarachnoid hemorrhage
Keywords: Aneurysmal subarachnoid hemorrhage; Delayed cerebral ischemia; Neurocritical care; Neuromonitoring; Nimodipine; Vasospasm.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Hoh B.L., Ko N.U., Amin-Hanjani S., Chou S.H.-Y., Cruz-Flores S., Dangayach N.S., Derdeyn C.P., Du R., Hänggi D., Hetts S.W., Ifejika N.L., Johnson R., Keigher K.M., Leslie-Mazwi T.M., Lucke-Wold B., Rabinstein A.A., Robicsek S.A., Stapleton C.J., Suarez J.I., Tjoumakaris S.I., Welch B.G. Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart association/American Stroke association. Stroke. 2023;54:e314–e370. doi: 10.1161/STR.0000000000000436. 2023. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
